Vet Project

Provandas is extending its at-home breath sampling technology to the veterinary space, developing a revolutionary multi-cancer detection test for dogs and cats that is non-invasive, simple to perform, and highly cost-effective. With cancer affecting 1 in 4 dogs and 1 in 3 cats during their lifetime, early detection is critical yet often limited by the high cost and invasiveness of current diagnostics. By leveraging advanced metabolomic analysis through high-resolution mass spectrometry, Provandas aims to enable veterinarians and pet owners to screen for multiple cancer types from a single breath sample—improving early intervention, outcomes, and quality of life for companion animals.

Human Project

Provandas is revolutionizing lung cancer screening with its AI-powered at-home breath test  offering a safe, non-invasive, and affordable alternative to traditional screening methods like low-dose CT scans, which expose patients to ionizing radiation and often miss non-smokers. As the number 1 cancer killer globally, lung cancer claimed approximately 1.8 million lives in 2020, accounting for about 18% of all cancer deaths (WHO).

With five-year survival rates hovering around 28% due to late-stage detection, Provandas’ high-resolution mass spectrometry and advanced AI analysis enable early, accurate identification of disease signatures from a simple breath sample, helping bridge the diagnostic gap and transforming preventive healthcare for one of the world’s deadliest cancers. Looking ahead, Provandas plans to expand its breath-based diagnostics platform to detect a broad range of cancers and infectious diseases, including tuberculosis, malaria, and HIV, creating a global framework for accessible, early disease detection.

Proposed Projects – Provandas Global Health & Environmental Initiative

1. Mobile Diagnostic Van Program – West Africa Pilot (Sierra Leone)

Provandas plans to expand its innovation into underdeveloped regions, starting with Sierra Leone, where access to reliable healthcare and laboratory diagnostics is limited.
Through our mobile diagnostic vans, equipped with breath-sample collection kits and digital analysis systems, trained field teams will travel across rural villages and hard-to-reach communities to collect samples.
These units will provide low-cost, non-invasive testing for tuberculosis (TB), HIV, and malaria, ensuring early detection and treatment in communities that often lack medical infrastructure.

Each van will operate as a mobile micro-lab, equipped with cooling systems, sample storage, and secure digital reporting tools to transmit results to local clinics and public health partners.

2. Community Health Partnership Program

Provandas will partner with national and district health authorities, community health workers, and local NGOs to strengthen early-diagnostic capacity and ensure long-term sustainability.
We will offer training in:

  • Breath-based sample collection and processing,

  • Safe data handling and transmission, and

  • Disease-surveillance reporting through mobile platforms.

This partnership model builds local ownership, creates rural employment opportunities, and supports government disease-control programs and global-health targets.

3. AI-Driven Disease Mapping and Predictive Analytics

Our mobile testing data will feed into an AI-driven disease-tracking dashboard designed to visualize infection trends and environmental correlations.
This platform will:

  • Generate real-time maps of disease occurrence,

  • Predict emerging outbreak zones using machine-learning models, and

  • Integrate with regional and global health databases (WHO, CDC Africa, etc.).

By transforming field diagnostics into actionable intelligence, Provandas will enable faster responses to public-health crises.

4. Environmental Monitoring and Air-Quality Surveillance

Recognizing the close link between environment and health, Provandas will integrate environmental monitoring sensors into its diagnostic vans.
These sensors will collect data on:

  • Air quality (PM₂.₅, PM₁₀, CO₂, NO₂, and volatile compounds),

  • Temperature and humidity, and

  • Local environmental stressors such as dust, smoke, and emissions.

By correlating air-quality data with disease occurrence, Provandas will help identify environmental drivers of respiratory infections and guide evidence-based interventions for cleaner, healthier communities.

5. Regional Expansion and Health–Environment Synergy

Following the Sierra Leone pilot, Provandas will expand into Liberia, Guinea, Ghana, and other West African nations, adapting the model to local health priorities and ecosystems.
The long-term goal is to establish a continental network of mobile diagnostic and environmental-monitoring units, contributing to both universal health coverage and climate-resilient public-health systems.

By combining biomedical innovation, AI-powered analytics, and environmental intelligence, Provandas aims to redefine how disease prevention and environmental stewardship intersect in developing regions.